The undersigned organizations write to express our concern that FDA has yet to issue any decisions on applications for marketing orders for menthol-flavored e-cigarettes or e-liquid products. We believe granting any such orders would be inconsistent with the agency’s marketing denial orders for other non-tobacco flavored products and would be harmful to public health, particularly to the health of young people.
Colorectal Cancer and the Importance of Screening
Colorectal cancer (cancer of the colon and rectum) is the third most common cancer in men and women and the second leading cause of cancer death in men and women combined in the United States. There has been a decline in colorectal cancer incidence and deaths in most adults over the last several decades due to improvements in early detection and treatment, increased uptake of screening, and changes in risk factors. Unfortunately, progress in colorectal cancer is slowing and screening rates remain low compared to other cancer screenings. In 2022, it is estimated that 151,030 people in the U.S. will be diagnosed with colorectal cancer, and an estimated 52,580 will die from the disease.